Stock screenerAll disclosures →
EDGAR →
PMN
Conviction 92HealthcareScan · Mon, Jul 20, 2026Shooting star
PMN$14.92-1.81%
ResistanceSupportVol 14Insider buyVol MA14 584.4K
Apr 20May 6May 26Jun 11Jul 1Jul 20
Price14.92
Change-1.81%
Gap-2.70%
Rel volume93.50×
Avg volume413.58K
Avg $ vol6.06M
SMA 2012.83
SMA 5011.32
SMA 2009.82
Price vs 50+31.80%
Price vs 200+51.82%
MA stackbullish
50/200 cross—
Supertrendup · 11.85
RSI (14)66
MACD hist0.15
MACD cross—
Stoch %K / %D70 / 74
ADX (14)36
+DI / −DI31 / 9
RSI divergence—
MACD divergence—
ATR %+7.83%
ADR %8.25%
52w high24.79
52w low0.2895
From 52w high-39.83%
Above 52w low+5051.99%
New 52w highNo
SqueezeOff
Bollinger width50.01%
%B0.83
Donchian pos74.11%
Donchian high16.58
Donchian low10.15
AVWAP (52w high)14.75
vs AVWAP high+1.09%
AVWAP (52w low)14.03
vs AVWAP low+6.34%
OBV trendDown
Chaikin MF (20)-0.71
Today vs 20d93.50×
Avg vol (14d)584.4K
Avg vol (20d)413.58K
Avg $ vol (20d)6.06M
Market cap133.75M
RS 3m (vs SPY)+22.36%
RS 6m (vs SPY)+78.94%
RS line new highYes
Trend template6/8
Technical rank96.1
1 week+16.52%
1 month+43.69%
3 months+29.36%
6 months+82.92%
1 year+3072.73%
YTD+109.04%
P/E-3.37
P/B2.20
P/S—
P/FCF-4.76
EPS-22.61
Div yield—
ROE-65.42%
ROA-58.92%
Debt/Eq0.00
Current9.92
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-1529.33%
Price target31.13
Target upside108.72%
Analyst ratingBuy
Institutional68.50%
Ent. value69.94M
Revenue—
Net income-8.24M
Gross profit—
Free cash flow-28.12M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out8.97M
Employees11
ListedFri, Sep 30, 2005
Free float7.88M
Float %87.9%
Short interest203.93K
Days to cover4.8d
Short volume48.4%
Squeeze score50 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$1.26
Last surprise—
Setup gradeA+
Conviction92 / 100
Pattern quality—
Tech rank96.1 / 100
Group rank23 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmShooting star
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in PMN
No recent disclosed trades by Congress in PMN. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in PMN · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Mandel-Brehm Josh Director · Option (right to buy) · 2026-05-20 | Grant | 11K | $0 | 2026-05-20 | 2026-05-22 |
Kaplan Johanne Chief Development Officer · Option (right to buy) · 2026-05-20 | Grant | 50K | $0 | 2026-05-20 | 2026-05-22 |
WYMAN WILLIAM W Director · Option (right to buy) · 2026-05-20 | Grant | 5.5K | $0 | 2026-05-20 | 2026-05-22 |
Warma Neil K Chief Executive Officer · Option (right to buy) · 2026-05-20 | Grant | 160K | $0 | 2026-05-20 | 2026-05-22 |
Williams Eugene Director · Option (right to buy) · 2026-05-20 | Grant | 5.5K | $0 | 2026-05-20 | 2026-05-22 |
Milbury Max A. Principal Accounting Officer · Option (right to buy) · 2026-05-20 | Grant | 18.17K | $0 | 2026-05-20 | 2026-05-22 |
Alex Slanix Paul Director · Option (right to buy) · 2026-05-20 | Grant | 5.5K | $0 | 2026-05-20 | 2026-05-22 |
Shafmaster Madge K. Director · Option (right to buy) · 2026-05-20 | Grant | 11K | $0 | 2026-05-20 | 2026-05-22 |
WYMAN WILLIAM W Director · Option (right to buy) · 2026-05-20 | Grant | 11K | $0 | 2026-05-20 | 2026-05-22 |
Williams Eugene Director · Option (right to buy) · 2026-05-20 | Grant | 11K | $0 | 2026-05-20 | 2026-05-22 |
SEC filings
EDGAR filings in PMN
No recent SEC filings on file for PMN.
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.